期刊文献+

卵巢癌术后复发介入化疗疗效分析(附18例临床报告) 被引量:3

Analysis of effect of the interventional treatment for the postoperantive recurrent ovarian carcinoma: report of eighteen cases
下载PDF
导出
摘要 目的:总结18例卵巢癌术后复发患者经介入动脉插管化疗的疗效,并对栓塞剂的应用进行了初步探讨。材料和方法:采用经皮股动脉穿刺双侧髂内动脉选择性插管的方法进行化疗灌注和栓塞。化疗方案为卡铂+表阿霉素(简称:CA方案),3例在CA方案的基础上加用足叶乙甙(VP-16),5例同时进行髂内动脉栓塞,所用栓塞材料包括明胶海绵碎块(2例)、顺铂微球(2例)、碘化油(1例)。结果:在15例可评价疗效的病例中,CR1例,PR6例,MR5例,SD2例,PD1例,有效率CR+PR为46.6%(7/15)。结论:动脉插管化疗是卵巢癌术后复发较合理的辅助疗法;卡铂+表阿霉素化疗方案对卵巢癌术后复发有较好疗效;进行髂内动脉栓塞化疗时选用明胶海绵碎块作栓塞剂,副作用较少。 Objective: To investigate the role of the interventional treatment for the postoperative recurrent ovarian carcinoma, the results in 18 cases were analysed, and rational application of the embolic materials in the treatment was discussed. Methods: The infusion chemotherapy and embolization of the bilateral internal iliac artery were performed using the Seldinger technique via the percutaneous femoral arterial catheterization. Chemotheraputic regimen was consisted of Carboplatin and (Epirubicin, EADR). Except for Carboplatin and EADR, Vp-16 was also administrated in 3 cases. The intra-arterial embolization in 5 cases was carried out with gelfoam fragment (2 cases), DDP-microspheres (2 cases) and lipiodol (1 cases). Results: The response rate (CR+PR) was 46.6% (7/15) with CR 1, PR 6 in 15 evaluable patinets. Conclusions: The results indicate the infusion chemotherapy and embolization of the internal iliac artery was a relatively good treatment modality for the postoperative recurrent ovarian carcinoma. The chemotheraputic regimen of Carboplatin+EADR had good effect to the patients. The side-effect was not serious as the gelfoam fragment was used in internal iliac arterial embolization.
出处 《癌症》 SCIE CAS CSCD 北大核心 1997年第6期433-434,460,共3页 Chinese Journal of Cancer
关键词 卵巢肿瘤 手术后 复发 介入疗法 药物疗法 Ovarian tumar, Infusion Ovarian tumar, Embolizaion Chemotherapy Internal artery
  • 相关文献

参考文献3

  • 1戴钟英,中华妇产科杂志,1995年,30卷,373页
  • 2杨继金,中华放射学杂志,1993年,27卷,517页
  • 3张惜阴,临床妇科肿瘤学,1993年,176页

同被引文献13

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部